Non-Current Assets
Accumulated Depreciation
AbbVie Accumulated Depreciation increased by 1.8% to $8.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $7.33B to $8.04B. Over 5 years (FY 2020 to FY 2025), Accumulated Depreciation shows an upward trend with a 7.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2015
Last reportedQ1 2026May 8, 2026
Parent metricPP&E (Net)
Metric ID:
ppe_accumulated_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.66B | $5.67B | $5.62B | $5.80B | $5.87B | $5.79B | $6.05B | $6.21B | $6.38B | $6.44B | $6.65B | $6.75B | $6.88B | $7.14B | $7.13B | $7.33B | $7.65B | $7.75B | $7.90B | $8.04B |
| QoQ Change | — | +0.3% | -1.0% | +3.3% | +1.1% | -1.4% | +4.6% | +2.6% | +2.6% | +1.0% | +3.2% | +1.5% | +2.0% | +3.8% | -0.1% | +2.8% | +4.3% | +1.2% | +2.0% | +1.8% |
| YoY Change | — | — | — | — | +3.8% | +2.0% | +7.7% | +7.0% | +8.6% | +11.3% | +9.8% | +8.6% | +7.9% | +10.8% | +7.3% | +8.7% | +11.2% | +8.5% | +10.8% | +9.7% |
| % of PP&E (Net) | 109.6% | 110.6% | 109.9% | 114.4% | 118.4% | 118.3% | 122.6% | 126.0% | 129.0% | 130.5% | 133.2% | 135.4% | 137.0% | 138.8% | 138.9% | 140.0% | 144.8% | 141.3% | 140.4% | 141.4% |
| Share Change | — | +1.0pp | -0.7pp | +4.4pp | +4.0pp | -0.1pp | +4.4pp | +3.3pp | +3.0pp | +1.6pp | +2.7pp | +2.2pp | +1.5pp | +1.9pp | +0.1pp | +1.1pp | +4.8pp | -3.5pp | -0.9pp | +1.0pp |
Range$5.62B – $8.04B
CAGR+7.7%
Avg YoY Growth+8.4%
Median YoY Growth+8.6%
Current Streak5 quarters growth
Accumulated Depreciation at Other Companies
Frequently Asked Questions
- What is AbbVie's accumulated depreciation?
- AbbVie (ABBV) reported accumulated depreciation of $8.04B in Q1 2026.
- How has AbbVie's accumulated depreciation changed year-over-year?
- AbbVie's accumulated depreciation increased by 9.7% year-over-year, from $7.33B to $8.04B.
- What is the long-term trend for AbbVie's accumulated depreciation?
- Over 5 years (2020 to 2025), AbbVie's accumulated depreciation has grown at a 7.1% compound annual growth rate (CAGR), from $5.61B to $7.90B.